GSTM1 and Schnyder corneal dystrophy: A very recent report updated the results of the RUBY trial on 32 SCD patients, with 31/32 patients reaching a condition of absence of vascular occlusive events after Reni-Cel infusion and with all patients reaching a normalization of Hb levels (13.8 ± 1.8 g/dL), with >40% of HbF [108].